144 ·Filed May 7, 2026

PBH

Prestige Consumer Healthcare Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001959173-26-003376
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale of minimal size. No immediate action needed, but monitor future filings for an increase in selling activity by officers, which could signal a shift in sentiment.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
PBH ▼ -4.89% at T+60d
NEUTRAL call ✗ call lost -4.89% · α vs SPY -8.72% · entry $54.59 → $51.92
Entry anchored
May 7, 02:32 PM ET
via exchange tick
T+1d
-3.76%
call -3.76% · α -4.59%
$52.54
settled 5mo ago
T+5d
-5.09%
call -5.09% · α -6.60%
$51.81
settled 5mo ago
T+20d
-16.76%
call -16.76% · α -19.90%
$45.44
settled 4mo ago
T+60d
-4.89%
call -4.89% · α -8.72%
$51.92
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Officer Jeffrey Zerillo filed a Form 144 to sell 305 shares of Prestige Consumer Healthcare, valued at approximately $16,580. The shares were acquired via restricted stock vesting. The sale is small relative to market cap ($2.6B) and follows other minor recent sales by the insider, indicating routine portfolio diversification rather than a negative signal.

Key Facts

  • Insider: Jeffrey Zerillo, Officer
  • Proposed sale: 305 shares common stock
  • Approximate value: $16,579.80 (based on filing date price ~$54.36/share)
  • Acquired via restricted stock vesting on 05/05/2026
  • Recent sales by same insider in preceding 3 months: 1,000 shares on 02/11/2026, 346 on 05/05/2026, 1,207 on 05/06/2026

Financial Impact

Insignificant; sale represents less than 0.001% of market cap ($2.6B)

Risk Factors

  • None material from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (10 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-003376
Document: 0001959173-26-003376-index.html0001959173-26-003376
Document: 0001959173-26-003376.txt0001959173-26-003376
5 reports for PBH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PBH — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
Press Release
BULLISH ★ 6/10
$54.43 $52.56▼ −3.44%▼ −4.04%$45.26 (−16.85%)
Jul 6, 2026
12w ago
Press Release
MIXED ★ 5/10
$48.86 $50.22▲ +2.78%▲ +3.35%$45.26 (−7.37%)
Jun 16, 2026
15w ago
8-K
MIXED ★ 6/10
$47.50 $47.19▼ −0.65%▼ −0.85%$45.26 (−4.72%)
May 13, 2026
20w ago
8-K
BEARISH ★ 7/10
$45.93 $47.82▼ −4.12%▼ −4.97%$45.26 (+1.46%)
May 7, 2026
21w ago
144
NEUTRAL ★ 2/10
$54.59 $45.44▼ −16.76%▼ −19.90%$45.26 (−17.09%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (37h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access